A new bronchodilator delivery device, SOBIstat-F, reduced hospitalization rates and improved clinical outcomes in children with severe acute asthma, according to a randomized clinical trial presented at the European Academy of Paediatrics (EAP) 2025. The study, conducted in two pediatric emergency departments in Asunción, Paraguay, involved 84 pediatric patients treated for severe asthma exacerbations…
Read More
About The Author
